Literature DB >> 10544149

Mutations of respiratory syncytial virus attachment glycoprotein G associated with resistance to neutralization by primate polyclonal antibodies.

W M Sullender1, K G Edwards.   

Abstract

The respiratory syncytial (RS) virus attachment glycoprotein G is a type II transmembrane glycoprotein and an important target of the host immune response. Antigenic variability of the G protein is postulated to contribute to the ability of the virus to evade established immune responses. A glycoprotein G monospecific polyclonal antiserum from a nonhuman primate was used to select for an antibody resistant RS virus. The mutant virus was resistant to neutralization by the selecting antiserum and by the sera from three other G-protein immunized primates. G-protein amino acid changes were found at residues 61 (Phe to Leu), 174 (Ser to Cys), and 183 (Trp to Leu). Thus the mutant protein had amino acid changes in the transmembrane domain (61) and the central ectodomain (174 and 183). The change at amino acid 174 resulted in five rather than the usual four Cys found in the conserved central region of the ectodomain. These data demonstrate that an RS virus with resistance to neutralization by polyclonal antibodies can be selected readily in cell culture. In addition, only a limited number of amino acid changes is required to produce the resistant phenotype. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544149     DOI: 10.1006/viro.1999.9987

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  Analysis of respiratory syncytial virus preclinical and clinical variants resistant to neutralization by monoclonal antibodies palivizumab and/or motavizumab.

Authors:  Qing Zhu; Josie M McAuliffe; Nita K Patel; Frances J Palmer-Hill; Chin-fen Yang; Brandon Liang; Lan Su; Wei Zhu; Leslie Wachter; Susan Wilson; Randall S MacGill; Subramaniam Krishnan; Michael P McCarthy; Genevieve A Losonsky; JoAnn A Suzich
Journal:  J Infect Dis       Date:  2011-01-05       Impact factor: 5.226

2.  In vivo selection of respiratory syncytial viruses resistant to palivizumab.

Authors:  Xiaodong Zhao; Wayne M Sullender
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Evolution of bovine respiratory syncytial virus.

Authors:  J F Valarcher; F Schelcher; H Bourhy
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  In vitro and in vivo fitness of respiratory syncytial virus monoclonal antibody escape mutants.

Authors:  Xiaodong Zhao; Enmei Liu; Fu-Ping Chen; Wayne M Sullender
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

5.  Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro.

Authors:  Matthew B Elliott; Karin S Pryharski; Qingzhong Yu; Christopher L Parks; Todd S Laughlin; C Kanta Gupta; Robert A Lerch; Valerie B Randolph; Natisha A LaPierre; Kristen M Heers Dack; Gerald E Hancock
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

6.  Genetic variability in G2 and F2 region between biological clones of human respiratory syncytial virus with or without host immune selection pressure.

Authors:  Claudia Trigo Pedroso Moraes; Danielle Bruna Leal Oliveira; Angelica Cristine Almeida Campos; Patricia Alves Bosso; Hildener Nogueira Lima; Klaus Eberhard Stewien; Alfredo Elias Gilio; Sandra Elisabete Vieira; Viviane Fongaro Botosso; Edison Luiz Durigon
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-02-03       Impact factor: 2.743

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.